PDF herunterladen
Open Access
CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2013; 03(04): 010-012
DOI: 10.1055/s-0040-1703694
Original Article

INCREASED VANCOMYCIN MINIMUM INHIBITORY CONCENTRATION (MIC) AMONG MRSA ISOLATES IN A TERTIARY CARE HOSPITAL

Authors

  • Asha Pai K. B.

    1   Assistant Professor, Department of Microbiology, K S Hegde Medical Academy, Nitte University, Deralakatte, Mangalore - 575 018, India

  • Sweetha N. N.

    2   Post Graduate, Department of Microbiology, K S Hegde Medical Academy, Nitte University, Deralakatte, Mangalore - 575 018, India

  • Sanjeev H.

    1   Assistant Professor, Department of Microbiology, K S Hegde Medical Academy, Nitte University, Deralakatte, Mangalore - 575 018, India

  • Rekha R.

    3   Professor, Department of Microbiology, K S Hegde Medical Academy, Nitte University, Deralakatte, Mangalore - 575 018, India

  • Vimal K. K.

    4   Professor & HOD, Department of Microbiology, K S Hegde Medical Academy, Nitte University, Deralakatte, Mangalore - 575 018, India

  • Ganesh H. R.

    5   Tutor, Department of Microbiology, K S Hegde Medical Academy, Nitte University, Deralakatte, Mangalore - 575 018, India
Weitere Informationen
Auch verfügbar auf
 als PDF herunterladen Lizenzen und Reprints
Preview

Abstract

Introduction:Methicillin Resistant Staphylococcus aureus (MRSA) is not only an important nosocomial pathogen but also an incipient community pathogen in many geographical areas. Recommended therapeutic agent for treatment of MRSA infections are glycopeptides, in particular vancomycin. The distribution of vancomycin Minimum Inhibitory Concentration (MIC) values among MRSA isolates in our hospital is unknown. We conducted this study to Determine the distribution of vancomycin MIC values among MRSA isolates from clinical samples in our hospital.

Material and Methods:Fifty six MRSA isolates were included in the study. These isolates were obtained from different clinical samples received in the department of Microbiology over a period of six months from august 2012 to January 2013. Screening for MRSA was done by disc diffusion method using Cefoxitin disc. Determination of vancomycin MIC of all the isolates was done by macro broth dilution method.

Results:All 56 isolates were sensitive to vancomycin. Out of the 56 isolates tested, 25 (44.64%) and 12 (21.4%) had Vancomycin MIC of 1μg/ml and 2 μg/ml respectively.

Conclusion:The high vancomycin MIC values observed among our strains are a cause of concern, as this may have an impact on the success of treatment with vancomycin.

Keywords

Methicillin Resistant Staphylococcus aureus - vancomycin MIC


Publikationsverlauf

Artikel online veröffentlicht:
26. April 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Tiwari HK, Sen MR. Emergence of Vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect dis.2006; 6:156-162.
  • 2 Coyle MB. In: Manual of antimicrobial susceptibility testing. American Society of Microbiology, Washington 2005:101-115.
  • 3 Dhanalakshmi TA, Umapathy BL, Mohan DR. Prevalence of methicillin, Vancomycin and multidrug resistance among Staphylococcus aureus. Journal of Clinical and Diagnostic Resarch.2012; 6(6):974-977.
  • 4 Howden BP, Davies JK, Johnson PDR, Stinear TP, Grayson ML. Reduced Vancomycin susceptibility in Staphylococcus aureus, including Vancomycin –intermediate and heterogenous Vancomycinintermediate strains: resistance mechanisms, laboratory detection and clinical implication. Clin Microbiol Rev. 2010; 23(1):99-139.
  • 5 Collee JG, Fraser AG, Marimon BP, Simmons A. In: Mackie and McCartney Practical medical microbiology.14 ed. Elsevier publication, New Delhi 2006:245-261.
  • 6 Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement M 100-S17. Approved standard. Wayne, PA, USA, 2007.
  • 7 Schwalbe R, Steele-Moore L, Godwin AC.In: Antimicrobial susceptibility testing protocols.CRC press, New York 2007:75-80.
  • 8 Ahmad N, Nawi S, Rajasekaran G, Maning N, Aziz MN, Husin A et al. Increased vancomycin inhibitory concentration among Staphylococus aureus isolates in Malaysia. J Med Microbiol. 2010; 59:1530-1532.
  • 9 Sakoulas G, Moise-Broder PA, Schentag J, Forest A, Mollering RC, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004; 42(6):2398-402.
  • 10 Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lomaestro BM et al. Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin. Antimicrob Agents Chemother. 2008; 52(9): 3315–3320.
  • 11 Sariano A, Marco F, Martinez JA, Pisos E, Almela M, Dimova VP et al. Influence of Vancomycin minimum inhibitory concentration on the treatment of methicillin resistant Staphylococcus aureus bacteraemia. Clin Infect Dis.2008; 46:193-200.